Patent details

EP2426145 Title: ENGINEERED ANTI-IL-23P19 ANTIBODIES

Basic Information

Publication number:
EP2426145
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP111720157
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ENGINEERED ANTI-IL-23P19 ANTIBODIES
French Title of Invention:
ANTICORPS ANTI-23P19 DE SYNTHÈSE
German Title of Invention:
GENTECHNISCH HERGESTELLTE ANTI-IL-23P19-ANTIKÖRPER
SPC Number:

Dates

Filing date:
21/02/2008
Grant date:
18/01/2017
EP Publication Date:
18/01/2017
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/03/2012
EP B1 Publication Date:
18/01/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
21/02/2017
Expiration date:
21/02/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
21/02/2008
 
 

Name:
Merck Sharp & Dohme Corp.
Address:
126 East Lincoln Avenue, Rahway, NJ 07065-0907, United States (US)

Inventor

1

Name:
Orth Peter
Address:
United States (US)

2

Name:
Presta Leonard G.
Address:
United States (US)

3

Name:
Liu Yan-Hui
Address:
United States (US)

4

Name:
Ingram Richard N.
Address:
United States (US)

5

Name:
Beyer Brian M.
Address:
United States (US)

Priority

Priority Number:
891413 P
Priority Date:
23/02/2007
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 16/24;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages